Ernexa Therapeutics plans IND filing for cancer cell therapy in Q3 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to Ernexa Therapeutics plans IND filing for cancer cell therapy in Q3 2026
(NASDAQ: ERNA) Delayed: 4.30 +0.14 (3.37%)
Previous Close $4.16    52 Week High $ 
Open $4.13    52 Week Low $ 
Day High $4.40    P/E N/A 
Day Low $4.13    EPS $ 
Volume 12,144